Topics

Glioblastoma | Treatment | Targeted therapy | Bevacizumab | Recurrence

Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Bevacizumab > Recurrence

Lü MJS, Michaelsen SR, Locallo A, Eickhart-Dalbøge CS, Scheie D, Melchior LC, Weischenfeldt J, Lassen U, Poulsen HS, Urup T.
Repeated responders to bevacizumab combination treatment in recurrent glioblastoma: a retrospective case study.
J Neurooncol. 2025 Jul 16. doi: 10.1007/s11060-025-05162-2. PMID: 40668315. Observational study. ˍ AI Overview

Qiu J, Zhu F, Quan R, Ye H, Su W, Wang R, Fu Y.
Comparative efficacy and safety of therapeutic strategies for EGFRvIII positive recurrent glioblastoma.
iScience. 2025 Aug 13;28(9):113346. doi: 10.1016/j.isci.2025.113346. PMID: 40917884. Meta-analysis. ˍ

Chen KT, Tsai HC, Huang CY, Liau CT, Ho KC, Toh CH, Chuang CC, Hsu PW, Huang YC, Chang TW, Yeap MC, Chen PY, Lee CC, Lin YJ, Feng LY, Airan RD, Li G, Lim M, Liu HL, Wei KC.
Combination of Neuronavigation-Guided Focused Ultrasound and Bevacizumab for Patients With Recurrent Glioblastoma: A Pilot Study.
Neurosurgery. 2025 Nov 24. doi: 10.1227/neu.0000000000003851. PMID: 41283685. Interventional study. ˍ

Akbas S, Alan O, Yildiz O, Karakurt M, Yildirim EC, Colak R, Yilmaz M, Celebi A, Er O, Celayir OM, Akdag MO, Sacli O, Ozcelik M, Sahin E, Ozdemir M, Dogu GG, Demir A, Gunaltili M, Elcicek OF, Sakalar T, Karabuga B, Yildiz F, Cavdar E, Ozkan O, Ozturk AE, Akagunduz B, Kuvvet BB, Selcukbiricik F.
Bevacizumab combined with irinotecan or temozolomide in recurrent glioblastoma: a Turkish Oncology Group (TOG) study.
J Neurooncol. 2026 Jan 5;176(2):152. doi: 10.1007/s11060-025-05415-0. PMID: 41492105. Observational study˰ ˍ